Minimally invasive therapy of lower urinary tract symptoms

The Urologic Clinics of North America
Robert F Donnell

Abstract

The establishment of guidelines, pharmacologic therapies, improved understanding of lower urinary tract symptoms (LUTS) versus benign prostate hyperplasia (BPH), respect for patient-centered goals, and improved discrimination of the patient with occult prostate cancer have empowered change in the management of LUTS. These developments have allowed urologists to recognize the limitations of transurethral prostatectomy as the gold standard and search for "ideal therapies" to provide treatments with an improved relief of symptoms, decreased complication rate and cost, to correct BPH-associated morbidities and prevent future morbidities. Prognostic parameters and their ability to predict progression may be important in the future of LUTS management and selection of therapy.

References

Feb 1, 1997·The Journal of Urology·J J de la RosetteF M Debruyne
Mar 1, 1997·British Journal of Urology·J D NawrockiJ P Ward
Aug 28, 1998·The Prostate·R DoggweilerR A Schmidt
Feb 24, 2001·The Laryngoscope·A Blitzer, L Sulica
May 11, 2001·Seminars in Neurology·A Brashear
Dec 6, 2001·Current Opinion in Ophthalmology·J O'Day
Jun 18, 2004·The Journal of Urology·Mark K PlantePeter Zvara
Aug 18, 2004·The Journal of Urology·Nobuyuki GoyaHiroshi Toma
Sep 2, 2004·International Urology and Nephrology·Andrei NaduAlexander Greenstein
Sep 17, 2004·The Journal of Urology·Konstantin Walmsley, Steven A Kaplan
Mar 31, 2005·Journal of Endourology·Barbara ErcoleManoj Monga
May 11, 2005·Urology·Osamu IkariNelson Rodrigues Netto
Jun 28, 2005·Trends in Neurosciences·Bazbek DavletovThomas Binz
Aug 2, 2005·Journal of Endourology·Stepan VeselyChrister Dahlstrand
Dec 20, 2005·Journal of Endourology·Andrew H TanHassan Razvi
Nov 7, 2006·The Journal of Urology·Yao-Chi Chuang, Michael B Chancellor
Dec 5, 2006·Current Opinion in Urology·Brian A VanderbrinkGopal H Badlani
Apr 18, 2007·The Journal of Urology·J N ArmitageJ H P van der Meulen
Dec 20, 2007·Current Opinion in Urology·Arash M Saemi, Mark K Plante

❮ Previous
Next ❯

Citations

Jul 27, 2011·The Journal of Urology·Piotr L ChlostaAndrzej Borówka
Nov 26, 2010·The Medical Clinics of North America·Thomas J Guzzo, George W Drach
Jul 15, 2015·Prostate Cancer and Prostatic Diseases·B J KingP Zvara
Dec 29, 2017·Prostate Cancer and Prostatic Diseases·Daniel MollengardenClaus Roehrborn
Jul 7, 2011·The Medical Journal of Australia·Henry H WooWilliam J Lynch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.